» Articles » PMID: 37252067

Application of Protection Motivation Theory to COVID-19 Vaccination Among a Predominantly Hispanic Sample of Adolescents

Overview
Journal Prev Med Rep
Date 2023 May 30
PMID 37252067
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the efficacy and widespread availability of COVID-19 vaccines, vaccine uptake has been relatively low in U.S. Hispanic communities, especially among adolescents. This study examined vaccination status among 444 high school students in predominantly Hispanic neighborhoods of Los Angeles County, California in May-June 2022 (mean age = 15.74 years, 55% female, 93% Hispanic). Guided by Protection Motivation Theory, we hypothesized that the odds of being fully vaccinated (at least 2 vaccine doses) would be significantly associated with higher levels of perceived severity, perceived vulnerability, response efficacy, and self-efficacy. 79% of the respondents were fully vaccinated. Binary logistic regression analyses found that response efficacy (belief in the effectiveness of the COVID-19 vaccine) and self-efficacy to get vaccinated were significantly associated with the likelihood of being fully vaccinated. Perceived severity of COVID-19 and perceived vulnerability to COVID-19 were not associated with the likelihood of being fully vaccinated. Results indicate that health communications are needed to convince Hispanic adolescents and their parents that the COVID-19 vaccine is effective, and outreach efforts are needed to remove barriers to vaccination among this population.

Citing Articles

Effect of educational intervention based on protection motivation theory on preventive behaviors of respiratory infections among hospital staff.

Rakhshani T, Nikeghbal S, Kashfi S, Kamyab A, Afzali Harsini P, Jeihooni A Front Public Health. 2024; 11:1326760.

PMID: 38249399 PMC: 10796505. DOI: 10.3389/fpubh.2023.1326760.

References
1.
Kowalski R, Deas N, Britt N, Richardson E, Finnell S, Evans K . Protection Motivation Theory and Intentions to Receive the COVID-19 Vaccine. Health Promot Pract. 2022; 24(3):465-470. PMC: 10159786. DOI: 10.1177/15248399211070807. View

2.
Griffin B, Conner M, Norman P . Applying an extended protection motivation theory to predict Covid-19 vaccination intentions and uptake in 50-64 year olds in the UK. Soc Sci Med. 2022; 298:114819. PMC: 8867961. DOI: 10.1016/j.socscimed.2022.114819. View

3.
Moghadas S, Vilches T, Zhang K, Wells C, Shoukat A, Singer B . The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States. Clin Infect Dis. 2021; 73(12):2257-2264. PMC: 7929033. DOI: 10.1093/cid/ciab079. View

4.
Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E . Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N Engl J Med. 2022; 386(16):1532-1546. PMC: 8908811. DOI: 10.1056/NEJMoa2119451. View

5.
MacDonald N . Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015; 33(34):4161-4. DOI: 10.1016/j.vaccine.2015.04.036. View